Literature DB >> 24595641

Immune responses to oral and IM administration of M2e-Hsp70 construct.

Farzaneh Assadian1, Gholamreza Nikbakht, Siavash Niazi, Reza Farahani Khaltabadi, Monireh Jahantigh.   

Abstract

The eukaryotic expression plasmid of M2e-Hsp70 is a candidate M2e-based DNA vaccine. In order to evaluate the immunization potential of this construct, Specific Pathogen Free chickens were immunized either intramuscularly or orally. Mutant Salmonella typhimurium was used as carrier for oral delivery of the M2e-Hsp70 construct. M2e-specific humoral and cellular responses were tested by ELISA and Lymphocyte Proliferation Assay, respectively. Our results indicate that both humoral and cellular immune responses are conferred against M2e-Hsp70 plasmid in either of the intramuscular or oral routes of administration; however, these responses are significantly higher in intramuscular injection in contrast to oral administration. When it comes to mass vaccination of commercial chicken flocks oral administration is preferred due to the ease of application as well as its capability of eliciting mucosal, humoral and cellular immune responses; so measurements should be taken to improve the immunization potency of our orally delivered DNA vaccine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24595641     DOI: 10.1007/s11259-014-9599-9

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  37 in total

Review 1.  DNA vaccines for poultry: the jump from theory to practice.

Authors:  Liz Haygreen; Fred Davison; Pete Kaiser
Journal:  Expert Rev Vaccines       Date:  2005-02       Impact factor: 5.217

2.  Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults.

Authors:  Christine B Turley; Richard E Rupp; Casey Johnson; David N Taylor; Julie Wolfson; Lynda Tussey; Uma Kavita; Lawrence Stanberry; Alan Shaw
Journal:  Vaccine       Date:  2011-05-30       Impact factor: 3.641

3.  Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.

Authors:  Shamaila Ashraf; Wei Kong; Shifeng Wang; Jiseon Yang; Roy Curtiss
Journal:  Vaccine       Date:  2011-04-03       Impact factor: 3.641

4.  Oral and nasal DNA vaccines delivered by attenuated Salmonella enterica serovar Typhimurium induce a protective immune response against infectious bronchitis in chickens.

Authors:  Hongmei Jiao; Zhiming Pan; Yuelan Yin; Shizhong Geng; Lin Sun; Xinan Jiao
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

5.  Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier.

Authors:  Roxana M Ionescu; Craig T Przysiecki; Xiaoping Liang; Victor M Garsky; Jiang Fan; Bei Wang; Robert Troutman; Yvette Rippeon; Elizabeth Flanagan; John Shiver; Li Shi
Journal:  J Pharm Sci       Date:  2006-01       Impact factor: 3.534

6.  Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.

Authors:  Keith Ameiss; Shamaila Ashraf; Wei Kong; Andrew Pekosz; Wai-Hong Wu; David Milich; Jean-Noel Billaud; Roy Curtiss
Journal:  Vaccine       Date:  2010-08-05       Impact factor: 3.641

Review 7.  DNA vaccines: developing new strategies against cancer.

Authors:  Daniela Fioretti; Sandra Iurescia; Vito Michele Fazio; Monica Rinaldi
Journal:  J Biomed Biotechnol       Date:  2010-03-28

8.  Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.

Authors:  P K Fagan; M J Walker; J Chin; G J Eamens; S P Djordjevic
Journal:  Microb Pathog       Date:  2001-02       Impact factor: 3.738

9.  Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

Authors:  V A Slepushkin; J M Katz; R A Black; W C Gamble; P A Rota; N J Cox
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

10.  The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine.

Authors:  Fan Wu; Xiao-Yi Yuan; Jing Li; Ying-Hua Chen
Journal:  Vaccine       Date:  2009-05-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.